Thu.Mar 20, 2025

article thumbnail

Practical Insights for Pharmacists on ADC Administration, Patient Experience, and Supportive Care

Pharmacy Times

Panelists discuss how antibody-drug conjugates (ADCs) often show more diverse outcomes in real-world settings compared with clinical trials, with varying efficacy and adverse effect profiles. Key practical considerations for pharmacists include appropriate dosing based on patient factors, managing drug interactions, implementing premedication protocols to minimize adverse reactions, and providing comprehensive supportive care.

article thumbnail

Eliquis vs. aspirin: Differences & similarities explained

The Checkup by Singlecare

Eliquis (apixaban) and aspirin are both oral drugs that decrease blood clotting, but that is where their similarities end. They thin the blood by very different mechanisms and are used for different medical conditions. How effective one is versus the other depends on the condition being treated. And their side effects and costs are quite different. Well compare and contrast Eliquis and aspirin so you better understand why your healthcare provider may recommend one over the other.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Tapping the potential of GLP-1 drugs requires integrated care and overcoming inequities, executives say

STAT

The GLP-1 class of drugs used to treat diabetes and obesity may have the potential to benefit huge swaths of the public, but ongoing employer concerns over cost and a lack of patient adherence remain stubborn obstacles to wider adoption, a pair of health executives explained Thursday. The medicines have proven wildly popular and, in turn, have generated huge sales, long stretches of shortages, and unchecked excitement among investors.

article thumbnail

Why take Zyrtec and Pepcid together?

The Checkup by Singlecare

There are several reasons one may consider taking Zyrtec and Pepcid together. They both block histamine receptors, but their mechanisms are different enough to have additive benefits. Zyrtec (cetirizine) is an antihistamine used for allergies , while Pepcid (famotidine) blocks gastric histamine-2 (H2) receptors and thereby decreases stomach acid production in the treatment of gastroesophageal reflux disease (GERD) and stomach ulcers.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: How to protect the American egg supply from avian flu  

STAT

Wholesale egg prices have dropped by more than 40% since late February, a decline that should soon translate into broader savings for consumers at grocery stores. This welcome respite has largely resulted from the lull in significant bird flu outbreaks in recent weeks, perhaps due to seasonal patterns in the virus’s transmission. North American flyways typically remain quiet in February as migratory birds have yet to start their journeys from their winter habitats.

article thumbnail

Patient Education When Initiating Treatment for Menopausal Symptoms

Pharmacy Times

Panelists note how medical professionals discuss menopause therapy, addressing symptoms, treatment options, safety concerns, adverse events, and personalized management strategies through patient-centered care. Professionals prioritize transparent communication, comprehensive risk assessment, and collaborative decision-making to ensure patient comfort and optimal management of menopausal transition.

More Trending

article thumbnail

Why Healthcare is Seeing an Increase in 2025 Ad Budgeting

Pharma Marketing Network

Introduction The healthcare industry is undergoing a significant transformation, and ad budgeting is at the center of this shift. With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025.

article thumbnail

Former CDC director Tom Frieden shares warning for RFK Jr. on measles outbreak

STAT

NEW YORK —   A former top federal health official is publicly warning Robert F. Kennedy Jr. that wavering on vaccines and slashing federal programs during a deadly measles outbreak could unleash the next public health disaster.  “The federal government might pause, but the measles virus doesn’t pause. Bacteria and viruses don’t pause.

article thumbnail

Pharma Ad Retargeting Basics

Pharma Marketing Network

Introduction The pharmaceutical industry faces unique challenges in digital marketing, especially when it comes to reaching healthcare professionals (HCPs) and patients effectively. Ad retargeting has become a powerful tool for pharma marketers, enabling brands to re-engage potential customers who have shown interest but have not yet converted. But how does ad retargeting work in pharma marketing, and what strategies yield the best results?

article thumbnail

Blood test for ovarian cancer misses some Black and Native American patients, study finds

STAT

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of  medical tests  that contribute to  health care disparities. Researchers have been working to uncover these kinds of biases in medicine. Recently, the Trump administration’s crackdown on diversity, equity and inclusion has  jeopardized such research  as universities react to political pressure and fe

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

The expanding use of GLP-1s

The Checkup by Singlecare

GLP-1 receptor agonists have greatly changed how we treat diabetes and obesity in recent years. Popular medications like Ozempic , Wegovy , and Zepbound have become popular not only for their ability to manage blood sugar levels but also for their impressive weight loss benefits. Beyond diabetes and weight loss, the use of GLP-1 medications is expanding into treatment for kidney disease, peripheral neuropathy, and potentially even dementia.

FDA
article thumbnail

STAT+: Gene therapies and CRISPR drugs slowed by ‘irrational pessimism,’ say scientists forging new paths

STAT

NEW YORK — To gene therapy pioneer Jim Wilson, the field is currently clouded with “irrational pessimism.” Companies are abandoning ship; approved therapies aren’t being prescribed. Yet both he and University of Pennsylvania researcher Kiran Musunuru are forging ahead, using contrasting approaches, as they explained onstage at STAT’s Breakthrough Summit East.

article thumbnail

European Pharmaceutical Review Issue 1 2025

European Pharmaceutical Review

Included in Issue 1 of European Pharmaceutical Review : FOREWORD AI in pharmaceutical development: hype or panacea? David Elder, David P Elder Consultancy IN-DEPTH FOCUS: MANUFACTURING AI-driven biomanufacturing: revolutionising production and quality in pharmaceuticals Ian Betteridge , European Pharmaceutical Review Regulating decentralised manufacturing in the UK – a legal perspective Harry Jennings, VWV law Advancing environmental monitoring systems for CGT manufacturing Gill Lewis, eXm

article thumbnail

Colonoscopy and AI: Experts weigh fuzzy evidence of benefit

STAT

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. A panel of experts at a leading speciality society announced in a new clinical guideline that they have decided not to decide whether to recommend AI-assisted colonoscopies.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

What is Being Done to Address Pharmacy Deserts in the US?

Drug Topics

Cencora representatives with expertise into pharmacy desert insights joined Drug Topics to discuss issues in pharmacy access and what is being done to address them.

article thumbnail

What happens when police and hospitals confiscate drugs?

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning! There’s sure to be a lot of news coming out of the Breakthrough Summit East today, which is taking place just a few blocks away from my favorite Shake Shack in Manhattan. In-person tickets are sold out, but you can still snag a virtual ticket here.

article thumbnail

Q&A: Knowledge is Key for Adapting AI within Pharmacy Practice

Drug Topics

Don Roosan, PharmD, PhD, joined Drug Topics to explore the future of ChatGPT in pharmacy practice and how AI is being used to manage patients medication regimens.

article thumbnail

STAT+: Pharmalittle: We’re reading about copycat weight loss drugs, ADHD prescriptions spiking, and more

STAT

Top of the morning to you, and a fine one it is, despite the dreary gray skies hovering over the Pharmalot campus. We are doing our best to maintain sunny spirits, though, because once again, we recall some helpful wisdom from the Morning Mayor, who taught us that “every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and inviting you to join us.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Expert Reflects on COVID-19 Pandemic 5 Years Later

Drug Topics

Pharmacists play a critical role in public education, and the potential for expanding clinical services is evident.

article thumbnail

STAT+: Pfizer’s Wall Street critic-turned-executive digs into the company’s problems, obesity plans

STAT

NEW YORK — In his first public comments, Pfizer’s new innovation chief — once a Wall Street analyst skeptical of the company — said he was confident in the company’s obesity plans and shed light on why he joined the pharmaceutical giant. Andrew Baum was managing director of equity research at Citigroup until last May, when Pfizer announced that he would take on the role of chief strategy and innovation officer.

article thumbnail

Q&A: Community Pharmacists Well-Positioned to Provide Injectable Contraception

Drug Topics

Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, clinical associate professor at University at Buffalo, discusses how pharmacists and patients view injectable contraception.

article thumbnail

STAT+: More research funding cuts and potential layoffs, from Columbia to AHRQ

STAT

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Happy Thursday, D.C. Diagnosis readers. I hope that you’ll be joining us at STAT’s Breakthrough Summit East today in New York either in person or virtually.

article thumbnail

Stopping SSRIs, SNRIs During Pregnancy Not Linked to Adverse Psychiatric Outcomes

Drug Topics

Discontinuing SSRIs or SNRIs during pregnancy did not lead to an increase in hospitalizations, outpatient visits, suicidal behavior, or sick leave use.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Optum Rx is shifting its payment models to better meet the needs of pharmacies and consumers, the pharmacy benefit manager announced Thursday. | Optum Rx is shifting its payment models to better meet the needs of pharmacies and consumers, the pharmacy benefit manager announced Thursday.

article thumbnail

Tandem’s Automated Insulin Delivery Technology Shows Improved Outcomes in T2D

Drug Topics

Control-IQ+ was associated with a greater reduction in glycated hemoglobin compared to a continuous glucose monitor alone.

article thumbnail

Study Reveals Virtual Reality Effectively Educates Pharmacists on Continuous Glucose Monitors

Pharmacy Times

Community pharmacists are uniquely positioned to assist with diabetes management using CGM devices.

article thumbnail

Oxford BioTherapeutics and Roche link on antibody cancer treatments

Pharmaceutical Technology

OBT has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Health tech company Inspiren developed intelligent AI-powered solutions for senior living that integrates care planning, resident safety, staff efficiency and emergency call functionalities into one system.

article thumbnail

Pfizer sells 7.3% stake in Haleon for $3.3bn

Pharmaceutical Technology

Pfizer has divested its residual shareholding in Haleon, representing 7.3% of the company's share capital, for a total of $3.3bn.

article thumbnail

Study Reports Challenges Screening Disordered Eating in Adults With Type 1 Diabetes

Pharmacy Times

Health care professionals in the study found it challenging to manage the complexities of disordered eating in patients with type 1 diabetes alongside their other responsibilities.

article thumbnail

Gantenerumab 'shows sign of preventing Alzheimer's dementia'

pharmaphorum

A study has suggested early targeting of amyloid in the brains of people with inherited Alzheimer's can delay symptoms, but not all are convinced.

article thumbnail

PAP 2025: The Impact of Out-of-Pocket Costs on Patients with Rare Diseases

Pharmaceutical Commerce

Jonathan James, CEO, Hope Charities, discusses the critical importance of maintaining access to life-saving medications for patients with rare diseases to lead productive lives.

article thumbnail

Expanded Use of Long-Acting Injectables for HIV and HIV Prevention

Pharmacy Times

As HIV treatment and prevention evolve, the use of long-acting injectables and their role in combating the HIV epidemic grows.